Analysis

While 89bio continues to advance its key Phase 3 trial for its flagship drug candidate, Pegozafermin, the company has received...

While much market attention remains fixed on technology behemoths, a compelling narrative is unfolding around the lesser-known equity, First /ME....

Footwear specialist Weyco finds itself navigating a complex set of market challenges. A difficult consumer spending backdrop and a dramatic...

While Nvidia continues to deliver extraordinary financial results, its shares are encountering unexpected turbulence. The company's latest quarterly performance exceeded...

Warren Buffett's Berkshire Hathaway has made a significant investment move, establishing a major position in UnitedHealth Group despite the healthcare...

A powerful rally among major US technology companies is serving as the primary catalyst for the iShares MSCI World ETF's...

Salesforce finds itself in a perplexing situation that has left investors grappling with mixed signals. The enterprise software giant posted...

A pivotal antitrust court decision involving Google has unexpectedly secured a multi-billion dollar revenue stream for Apple, providing a significant...

Lockheed Martin Corporation (NYSE: LMT) experienced an extraordinary week, securing two massive defense contracts totaling nearly $10.7 billion. The significant...

Eli Lilly has generated significant attention in oncology circles following the FDA's decision to grant its lung cancer treatment Olomorasib...